Glofitamab and epcoritamab in the real-world setting: a UK multi-center retrospective analysis
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2025-01-09
Просмотров: 164
Описание:
In this video, Wendy Osborne, MBBS (Hons), MRCP, FRCPath, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK, discusses the efficacy and tolerability of bispecific antibodies (epcoritamab and glofitamab) in a real-world cohort of patients with non-Hodgkin lymphoma (NHL) in the United Kingdom. Dr Osborne highlights the encouraging efficacy of these agents in a high-risk patient population. This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
![Why 95% of Healthcare AI Fails and How Post-Acute Care Can Scale Automation That Works [INOvators]](https://image.4k-video.ru/id-video/ahaO9Tre9L4)
